Gender, Racial, and Geographical Disparities in Malignant Brain Tumor Mortality in the USA
Oncology · 2024 · 102 (8) · 703-709
DOI: 10.1159/000536486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 27.01.2024. Verfasst von Jia Yi Tan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Brain Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Introduction
Malignant brain tumors are malignancies which are known for their low survival rates. Despite advancements in treatments in the last decade, the disparities in malignant brain cancer mortality among the US population remain unclear.
Methods
We analyzed death certificate data from the US CDC WONDER from 1999 to 2020 to determine the longitudinal trends of malignant brain tumor mortality. Malignant brain tumor (ICD-10 C71.0–71.9) was listed as the underlying cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 individuals were calculated by standardizing the AAMR to the year 2000 US population.
Results
From 1999 to 2020, there were 306,375 deaths due to malignant brain tumors. The AAMR decreased from 5.57 (95% CI, 5.47–5.67) per 100,000 individuals in 1999 to 5.40 (95% CI, 5.31–5.48) per 100,000 individuals in 2020, with an annual percent decrease of −0.05 (95% CI, −0.22, 0.12). Whites had the highest AAMR (6.05 [95% CI, 6.02–6.07] per 100,000 individuals), followed by Hispanics (3.70 [95% CI, 3.64–3.76]) per 100,000 individuals, blacks (3.09 [95% CI, 3.04–3.14] per 100,000 individuals), American Indians (2.82 [95% CI, 2.64–3.00] per 100,000 individuals), and Asians (2.44 [95% CI, 2.38–2.50] per 100,000 individuals). The highest AAMRs were reported in the Midwest region (5.58 [95% CI, 5.54–5.62] per 100,000 individuals) and the rural regions (5.66 [95% CI, 5.61–5.71] per 100,000 individuals).
Conclusions
Our study highlights the mortality disparity among different races, geographic regions, and urbanization levels. The findings underscore the importance of addressing the disparities in malignant brain tumors that existed among males, white individuals, and rural populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA.
- Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Internal Medicine/Pediatrics, Corewell Health, Royal Oak, Michigan, USA.
- St George's University School of Medicine, St George's, Grenada.
Zitieren
APA
Tan, J. Y., Thong, J. Y., Yeo, Y. H., Mbenga, K., & Saleh, S. (2024). Gender, Racial, and Geographical Disparities in Malignant Brain Tumor Mortality in the USA. Oncology, 102(8), 703-709. https://doi.org/10.1159/000536486
Vancouver
Tan JY, Thong JY, Yeo YH, Mbenga K, Saleh S. Gender, Racial, and Geographical Disparities in Malignant Brain Tumor Mortality in the USA. Oncology. 2024;102(8):703-709. doi:10.1159/000536486
BibTeX
@article{Tan2024,
author = {Tan, Jia Yi and Thong, Jia Yean and Yeo, Yong Hao and Mbenga, Kelly and Saleh, Sabera},
title = {Gender, Racial, and Geographical Disparities in Malignant Brain Tumor Mortality in the USA},
journal = {Oncology},
year = {2024},
volume = {102},
number = {8},
pages = {703--709},
doi = {10.1159/000536486}
}
EUVIMED